Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 764
The Myelin Disorders Biorepository Project
for
Leukodystrophy, White Matter Disease, Leukoencephalopathies,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT03047369
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Washington D.C. DC, Bethesda MD, Falls Church VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase3, Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
for
Diffuse Intrinsic Pontine Glioma,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: University of California, San Francisco
Sex: All
Age: 2 - 39
Code: NCT05009992
Phase2, Recruiting
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for
Neoplasms, Child, Adolescent
Location: Washington D.C. DC, Pittsburgh PA, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 1 - 39
Code: NCT05999994
Phase2, Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Washington D.C. DC, Bethesda MD, Elkton MD, Newark DE,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
for
Pulmonary Invasive Fungal Infections,
Location: Washington DC, Philadelphia PA, New York NY,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 21
Code: NCT03827694
Recruiting
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma